Company facts
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Virginia Beach, Virginia
- Most recent report
- 8-K, filed Oct 7, 2026
- Filings on record
- 253 filings
- On EDGAR
- CIK 1310488
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 41
News 8 of 48
Prospectuses and Registrations 4
Proxies 1
Ownership 8 of 82
- SCHEDULE 13D Large holder reported an active stake Sep 4, 2026
- 3 Insider reported their initial holding Sep 4, 2026
- 3 Insider reported their initial holding Sep 3, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Oct 18, 2023
- 4 Insider reported a trade Oct 18, 2023
- 4 Insider reported a trade Dec 14, 2022
Other 8 of 77
- NT 10-Q Notice that a quarterly report will be late May 13, 2026
- NT 10-K Notice that an annual report will be late Mar 31, 2026
- NT 10-Q Notice that a quarterly report will be late Nov 13, 2025
- NT 10-K Notice that an annual report will be late Mar 28, 2025
- UPLOAD Comment letter from SEC staff Dec 31, 2019
- DEFR14C Dec 31, 2019
- DEFR14C Dec 31, 2019
- DEF 14C Dec 31, 2019
Everything here comes from Bioforce Nanosciences Holdings, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.